Grifols, S.A. ( GIFLF) - Key Metrics
Stock symbol GIFLF is outdated, potentially delisted? Maybe it is available on other exchange?
GIFLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $2.88 | $0.14 | ? | ? |
| 2025Q3 | $2.74 | $0.19 | $0.48 | $0.38 |
| 2025Q2 | $2.75 | $0.17 | $0.23 | $0.14 |
| 2025Q1 | $2.62 | $0.09 | $0.20 | $0.13 |
| 2024Q4 | $2.90 | $0.10 | $0.76 | $0.61 |
GIFLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 18.75 |
| 2025Q3 | 80.64% | 16.52 |
| 2025Q2 | ? | 15.22 |
| 2025Q1 | ? | 23.35 |
| 2024Q4 | 1.39% | 22.57 |
GIFLF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | ? | ? |
| 2025Q3 | 3.04% | 1.22% |
| 2025Q2 | 1.33% | ? |
| 2025Q1 | 1.55% | ? |
| 2024Q4 | 6.66% | 0.02% |
GIFLF
Price: $12.90
52 week price:
Dividend Yield: 1.54%
Payout Ratio Range:
Earnings Per Share: 0.65 USD
P/E Ratio: 17.94
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 7.9 billion